Areas › Focus, starting, and ADHD › Medication and how it works
In practice the non-stimulants turn up more often as an addition than on their own. A stimulant in the morning with guanfacine alongside it is a common shape.
The two act at different points of the same circuit, so they tend to complement rather than repeat each other, and the blood pressure effect of one can take the edge off the other. Being on two medicines can feel like the first one failed. It usually is not that, and any addition still deserves a clear reason and a date to look at it again.
This explains how treatments work. Never start, stop or change a medication because of something you read here.
Qur’an and Sunnah
The believers are those who 'conduct their affairs by mutual consultation' (Quran 42:38). A regimen with more than one medicine in it should be arrived at the same way, out loud and together.
وَٱلَّذِينَ ٱسۡتَجَابُواْ لِرَبِّهِمۡ وَأَقَامُواْ ٱلصَّلَوٰةَ وَأَمۡرُهُمۡ شُورَىٰ بَيۡنَهُمۡ وَمِمَّا رَزَقۡنَٰهُمۡ يُنفِقُونَ
respond to their Lord; keep up the prayer; conduct their affairs by mutual consultation; give to others out of what We have provided for them
Qur’an 42:38read it in the library
Translation: M.A.S. Abdel Haleem, The Qur'an, Oxford University Press, 2004.
What the research says
A review of adult ADHD treatment reports that stimulant effect sizes approach those seen in school-age children once doses are adequate, with atomoxetine and bupropion described as second-line options. That ordering is what leaves the non-stimulants in a supporting role for most people. It is a review rather than a trial of combinations, and combinations are much less well studied than either drug alone.
Santosh PJ, Sattar S, Canagaratnam M. (2011). Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.. CNS drugs doi
Strength of evidence: one line of research. A single study, or a theoretical account.
Why it works
Two medicines reaching the same circuit by different doors can do together what neither manages alone.
This one is still a draft. It is waiting on a scholar and a clinician to read it before it is published.
Near this one
Parents often ask whether starting a stimulant now makes drug problems more likely later. The question deserves the actual evidence, gently given, rather than reassurance.
These are among the best studied medicines in psychiatry, in use for decades. Most of the hesitancy around them traces back to how they get covered in the press rather than to the safety record.
The old argument about medication against behaviour therapy was set down years ago. The useful question now is what each one covers.